Smith Beth Ann's Form 4 filing
Macrogenics Inc (MGNX) · filed Feb 19, 2025
- Accession no.
- 0001125345-25-000031
- Filed
- Feb 19, 2025
- Trade date
- Feb 15, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.08K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Smith Beth AnnCIK 0002051299 | Officer (VP, Controller & Treasurer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 15, 2025 | Common Stock | MOption exerciseAcquired | +1,095 | $0.00F1 | $0 | 9,955 | Direct | |
| Feb 15, 2025 | Common Stock | SSaleDisposed | −423 | $2.56 | −$1,082.88 | 9,532 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 15, 2025 | Common Stock | MOption exerciseDisposed | −1,095 | $0.00 | $0 | 1,095 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
On February 15, 2023 the reporting person was granted 3,285 restricted stock units, 33% of which vested on February 15, 2024 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis.
Referenced by the price of 1 transaction in Table I.